Yarrow Bioscience, Inc. YARW
15.48 USD -0.31 (-1.96%)
At closeNov 10, 2026, 4:00 PM EST
15.48 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
14.80 Day range 17.81
12.39 52-week range 46.95
- YTD
- -46.62%
- 1 year
- -14.71%
News
benzinga.com This Palatin Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday Analysts initiated coverage: Neutral on KEEL ($2), Buy on PTN ($12), FRVO ($17) and YARW ($60).
benzinga.com Guggenheim Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $60 Guggenheim analyst Yatin Suneja initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $60.
benzinga.com Yarrow Bioscience Launches Underwritten Public Offering To Fund Pipeline Development And Corporate Operations; No Terms Disclosed Yarrow Bioscience, Inc. ("Yarrow" or the "Company") (NASDAQ:YARW), a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, today…
benzinga.com Yarrow Bioscience Q2 EPS $(2.14) Misses $(0.22) Estimate Yarrow Bioscience (NASDAQ:YARW) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(0.22) by 872.73 percent.
benzinga.com This Charles Schwab Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Monday Wall Street analysts changed outlook on top names. For full changes, see our analyst ratings page. Analysts have mixed opinions on SCHW stock.- benzinga.com BTIG Initiates Coverage On Yarrow Bioscience with Buy Rating, Announces Price Target of $58 BTIG analyst Julian Harrison initiates coverage on Yarrow Bioscience (NASDAQ:YARW) with a Buy rating and announces Price Target of $58.